Researchers have found a way to harness COVID-19 T cells from a person who has had the virus, by re-engineering them to identify and attack cancer cells when re-injected into the body."This new research is really exciting, it uses COVID-19 immunity, T 'killer' cells, to recognise covid, engineers them to attack breast cancer cells - really clever," Professor Robert Booy said.So far, the therapy has shown promise in treating some blood cancers but not as effective with solid tumours like breast cancer.
the Peter MacCallum Cancer Centre and University of Melbourne
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.8¢ | 6.9¢ | 6.6¢ | $647.9K | 9.625M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 309078 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 759722 | 11 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.7¢ |
Change
0.000 ( 0.15 %) |
||||
| Open | High | Low | Volume | ||
| 6.8¢ | 6.9¢ | 6.6¢ | 3602017 | ||
| Last updated 15.57pm 31/05/2024 ? | |||||
| IMU (ASX) Chart |